Menu
GeneBe

rs8096092

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_005359.6(SMAD4):c.667+238C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.387 in 151,950 control chromosomes in the GnomAD database, including 11,421 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.39 ( 11421 hom., cov: 32)

Consequence

SMAD4
NM_005359.6 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.710
Variant links:
Genes affected
SMAD4 (HGNC:6770): (SMAD family member 4) This gene encodes a member of the Smad family of signal transduction proteins. Smad proteins are phosphorylated and activated by transmembrane serine-threonine receptor kinases in response to transforming growth factor (TGF)-beta signaling. The product of this gene forms homomeric complexes and heteromeric complexes with other activated Smad proteins, which then accumulate in the nucleus and regulate the transcription of target genes. This protein binds to DNA and recognizes an 8-bp palindromic sequence (GTCTAGAC) called the Smad-binding element (SBE). The protein acts as a tumor suppressor and inhibits epithelial cell proliferation. It may also have an inhibitory effect on tumors by reducing angiogenesis and increasing blood vessel hyperpermeability. The encoded protein is a crucial component of the bone morphogenetic protein signaling pathway. The Smad proteins are subject to complex regulation by post-translational modifications. Mutations or deletions in this gene have been shown to result in pancreatic cancer, juvenile polyposis syndrome, and hereditary hemorrhagic telangiectasia syndrome. [provided by RefSeq, May 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BP6
Variant 18-51055231-C-A is Benign according to our data. Variant chr18-51055231-C-A is described in ClinVar as [Benign]. Clinvar id is 677079.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.434 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SMAD4NM_005359.6 linkuse as main transcriptc.667+238C>A intron_variant ENST00000342988.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SMAD4ENST00000342988.8 linkuse as main transcriptc.667+238C>A intron_variant 5 NM_005359.6 P1

Frequencies

GnomAD3 genomes
AF:
0.387
AC:
58704
AN:
151832
Hom.:
11405
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.390
Gnomad AMI
AF:
0.613
Gnomad AMR
AF:
0.402
Gnomad ASJ
AF:
0.403
Gnomad EAS
AF:
0.450
Gnomad SAS
AF:
0.254
Gnomad FIN
AF:
0.397
Gnomad MID
AF:
0.392
Gnomad NFE
AF:
0.380
Gnomad OTH
AF:
0.406
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.387
AC:
58781
AN:
151950
Hom.:
11421
Cov.:
32
AF XY:
0.385
AC XY:
28583
AN XY:
74276
show subpopulations
Gnomad4 AFR
AF:
0.390
Gnomad4 AMR
AF:
0.403
Gnomad4 ASJ
AF:
0.403
Gnomad4 EAS
AF:
0.449
Gnomad4 SAS
AF:
0.253
Gnomad4 FIN
AF:
0.397
Gnomad4 NFE
AF:
0.380
Gnomad4 OTH
AF:
0.410
Alfa
AF:
0.381
Hom.:
1810
Bravo
AF:
0.395
Asia WGS
AF:
0.378
AC:
1310
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxJun 16, 2018This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.98
Cadd
Benign
0.14
Dann
Benign
0.25

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs8096092; hg19: chr18-48581601; API